“…For instance, mice overexpressing vascular endothelial growth factor (VEGF)-A or VEGF-C in a model of chemically induced skin carcinogenesis showed prominently enhanced LN lymphangiogenesis, concomitant with a significant increase of LN and distant organ metastasis ( Hirakawa et al., 2005 , Hirakawa et al., 2007 ). Importantly, these and other studies using experimental models of nasopharyngeal carcinoma ( Qian et al., 2006 ) and malignant melanoma ( García-Caballero et al., 2017 , Harrell et al., 2007 ) have identified the onset of LN lymphatic remodeling prior to the colonization of the LN by metastatic cells. These data suggest that, even in the absence of metastatic tumor cells, tumor-associated lymphangiogenic factors can be drained from the primary tumor or released by locally activated cells to initiate changes in preparation of a pre-metastatic “lymphovascular niche” ( Hirakawa et al., 2005 , Ogawa et al., 2014 , Olmeda et al., 2017 ).…”